Trial NCT00033449

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02462
Secondary IDs: CDR0000069284 UCHSC-01460

Last trial update was posted on 2013-01-25

MeSH Interventions

Gefitinib

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Laryngeal Diseases Laryngeal Neoplasms Oropharyngeal Neoplasms Squamous Cell Carcinoma of Head and Neck

Other Conditions

Stage III Squamous Cell Carcinoma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Squamous Cell Carcinoma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IV Squamous Cell Carcinoma of the Oropharynx

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID